Cardiac stimulation in atrial fibrillation
Authors:
K. Buchtová
Authors‘ workplace:
LF MU a FN U sv. Anny, Brno
; I. interní kardioangiologická klinika
Published in:
Kardiol Rev Int Med 2007, 9(1): 31-39
Category:
Editorial
Overview
Atrial fibrillation is one of the most frequent arrhythmia whose incidence increases with age. Atrial fibrillation occurs most often in chronic illnesses, for instance in hypertension, heart failure, coronary heart disease, valve defects, cardiomyopathy, but non-cardiac causes are also possible, including hyperthyroidism or ion imbalances. The decision as to whether to use pharmacological or non-pharmacological treatment or a combined (hybrid) form of treatment must be made individually for every patient with atrial fibrillation. In this work we consider indication for the implantation of a pacemaker for permanent atrial fibrillation, for sinus node malfunction with paroxysmal atrial fibrillation, for patients with chronic atrial fibrillation after ablation of the atrioventricular junction and biventricular stimulation in patients with heart failure and atrial fibrillation. Implantation of a pacemaker is not usually the method of first choice – it is always necessary to weigh the benefit of pacemaker implantation against the possible complications. Special attention is given to algorithms for the prevention of atrial tachyarrhythmia.
Keywords:
atrial fibrillation – long-term cardiac stimulation – sick sinus syndrome – preventative algorithms – non-selective ablation of the AV node – heart resynchronisation therapy
Sources
1.Čihák R, Heinz P. Guidelines pro léčbu fibrilace síní - Česká kardiologická společnost 2004. Cor Vasa 2004; 46: 67-77.
2.ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation. 2001; 104(17): 2118-2150.
3.Fiala M. Doporučené postupy pro diagnostiku a léčbu supraventrikulárních arytmií. Cor Vasa 2005; 47(Suppl 9): 18-69.
4.Táborský M, členové výboru PS AKS ČKS. Zásady pro implantace kardiostimulátorů a implantabilních kardioverterů-defibrilátorů pracovní skupiny Arytmie a trvalá kardiostimulace České kardiologické společnosti. Cor Vasa 2005; 47: 59-68.
5.Gregoratos G, Abrams J, Epstein AE et al. ACC/AHA/NASPE Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices Summary Article. Circulation 2002; 106: 2145-2161.
6.Andersen HR, Nielsen JC, Thomsen PE et al. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick sinus syndrome. Lancet 1997; 350: 1210-1216.
7.Skanes AC, Krahn AD, Yee R et al for the CTOPP investigators. Progression to chronic atrial fibrillation after pacing: the Canadian trial of physiologic pacing. J Am Cardiol 2001; 38: 167-172.
8.Fleischmann KE, Orav EJ, Lamas GA et al. Pacemaker implantation and quality of life in the Mode Selection Trial (MOST). Heart Rhythm 2006; 3(6): 653-659.
9.Novák M, Kamarýt P, Dvořák I jr et al. Is the atrial pacemaker a reliable solution in the treatment of patients with the sick sinus syndrome? Cor Vasa 2002; 44(12): 509-512.
10.Anselme F, Saoudi N, Cribier A et al. Pacing for prevention of atrial fibrillation: the PIPAF studies. J Intervent Cardiac Electrophysiol 2000; 4: 177-184.
11.Táborský M, Neužil P, Šedivá L, Niederle P. Trvalá kardiostimulace v prevenci vzniku a udržení fibrilace síní. Kardiol Rev 2002; 2: 135-140 .
12.Blanc JJ et al. Atrial pacing for prevention of atrial fibrillation: accessement of simultanneously implement algorithms. Europace 2004; 6(5): 371-379.
13.Masumoto H et al. Long-term clinical performance of AAI pacing in patients with sick sinus syndrome: a comparison with dual-chamber pacing. Europace 2004; 6(5): 444-450.
14.Israel C. The role of pacing mode in the development of atrial fibrillation. Europace 2006; 8(2): 89-95.
15.Levy T, Walker S, Rochelle J et al. Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation. Am J Cardiol 1999; 84: 426-429.
16.Becker R, Klinkott R, Bauer A et al. Multisite pacing for prevention of atrial tachyarrhythmias: potential mechanismus. J Am Coll Cardiol 2000; 35(7): 1939-1946.
17.Bailin SJ, Adler S, Guidici M. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann ´s bundle: results of a multicenter randomized trial. J Cardiovasc Electrophysiol 2001; 12: 912-917.
18.Frohlig G, Gras D, Victor J, Mabo P et al. Use of new cardiac pacing mode designed to eliminate unnecessary ventricular pacing. Europace 2006; 8(2): 96-101.
19.Hemels M, Wiesfeld A et al. Right atrial overdrive pacing for prevention of symptomatic refractory atrial fibrillation. Europace 2006; 8:107-112.
20.Fitts SM, Hill MR, Mehra R et al. Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial. DAPPAF Phase 1 Investigators. Interv Card Electrophysiol 1998; 2(2): 139-144.
21.Carlson M et al. A New pacemaker algorithm for the treatement of atrial fibrillation, results of the atrial dynamic overdrive pacing trial ( ADOPT). J Am Coll Cardiol 2003; 42(4): 627-633.
22.Feld GK, Fleck RP, Fijimura O et al. Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation. Circulation 1994; 90: 2299-2307.
23.Williamson BD et al. Radiofrequency catheter modification of the atrioventricular conduction to control ventricular rate during atrial fibrillation. N Engl Med 1994; 331: 910-917.
24.Procleemer A, Della BP, Tondo C et al. Radiofrequency ablation of atrioventricular junction and pacemaker implantation versus modulation of atrioventricular conduction in drug refractory atrial fibrillation. Am J Cardiol 1999; 83: 1437-1442.
25.Táborský M, Neužil P. Neselektivní ablace AV uzlu - nové aspekty v době kurativní léčby fibrilace síní a srdeční resynchronizační terapie. Kardiol Rev 2006; 8(Suppl): 10-12.
26.Fiala M. Kontrola frekvence komor při fibrilaci síní. Kardiol Rev 2002; 2: 120-124.
27.Kay GN, Ellenboen KA et al. The ablate and pace trial. A prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatement of atrial fibrillation. J Intervent Cardiac Electrophysiol 1998; 2: 121-135.
28.Geelen P, Goethals M, de Bruyere B et al. A prospective hemodynamic evaluation of patients with chronic atrial fibrillation undergoing radiofrequency catheter ablation of the atrioventricular junction. Am J Cardiol 1997; 80: 1606-1609.
29.Oszan C, Jaganhir A, Friedman PA et al. Long term survival after ablation of the atrioventricular node and implantation of the permanent pacemaker in patients with atrial fibrillation. N Engl J Med 2001; 344: 1043-1051.
30.Crijns HJCG, Tjeerdsma G et al. Prognostic value of presence and development of atrial fibrillation in patients with with advanced chronic heart failure. Eur Heart J 2000; 21(15): 1238-1245.
31.Valls-Bertault V et al. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation. Europace 2004; 6: 438-443.
32.Leclerc C, Walker S, Linde C et al. Comparative effect of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002; 23: 1780-1787.
33.Sweeney MO, Hellkamp AS et al. Adverse effect of ventricular pacing on heart failure and a atrial fibrillation among patients with normal baseline QRS duration in a clinical trail of pacemaker therapy for sinus node dysfunction. Circulation 2003; 107(23): 2932-2937.
34.Kies P, Leclerc C, Bleeker GB, Crocg C et al. Cardiac resynchronization therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart 2006; 92(4): 490-494.
35.Molhoek SG, Bax JJ, Bleeker GB et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiology 2004; 94(12): 1506-1509.
36.Leon RL, Greenberg JM et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation. J Am Cardiol 2002; 6: 438-443.
Labels
Paediatric cardiology Internal medicine Cardiac surgery CardiologyArticle was published in
Cardiology Review
2007 Issue 1
Most read in this issue
- Cardiac stimulation in atrial fibrillation
- Right ventricular infarction
- Combined therapy of dyslipidemia
- Right ventricle perforation by defibrillation lead – a conservative approach? A case report.